IP Library Assignment 046607/0239
Patent Assignment
Reel/Frame 046607/0239

Assignment of Assignor's Interest

Recorded: 2018-08-09 Pages: 11
Assignors
NIELSEN, ULRIK
Executed: 2011-07-28
WICKHAM, THOMAS
Executed: 2011-07-26
SCHOEBERL, BIRGIT
Executed: 2011-07-26
HARMS, BRIAN
Executed: 2011-07-26
LINGGI, BRYAN
Executed: 2011-07-22
ONSUM, MATTHEW
Executed: 2011-08-05
DELABARRE, BYRON
Executed: 2011-07-12
LIPPOW, SHAUN M.
Executed: 2011-08-08
Assignee
MERRIMACK PHARMACEUTICALS
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties (2)
Bi-Specific Fusion Proteins
Application: 15/618,478 →
Publication: US 2017/0335015
A method of treating myocardial infarction by administering a bi-specific fusion protein
Patent: 9,718,892 →
Application: 14/967,980 →
Publication: US 2016/0168269
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 8, 2019
From: MERRIMACK PHARMACEUTICALS, INC.
To: SILVER CREEK PHARMACEUTICALS, INC.
Reel/Frame 049112/0597 →
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 046607 Frame 0239. Assignor(S) Hereby Confirms the Assignment. Jun 17, 2019
From: NIELSEN, ULRIK; WICKHAM, THOMAS; SCHOEBERL, BIRGIT; HARMS, BRIAN
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 049485/0230 →